Ovulation Test Market Overview
The Ovulation Test Market is anticipated to reach USD3642.96 Million by 2030 at 6.3% CAGR during the forecast period 2022-2030.
Ovulation is a process in the body in which the release of the eggs happens. The test is a kit that identifies luteinizing hormones that flow in the body just before ovulation. With the help of the ovulation kit, couples can find out the best time to have sex in order to increase the possibility of getting pregnant. There is a huge demand for ovulation kits in the market these days. Every month the female body produces luteinizing hormones during the menstrual cycle. Ovulation tests help to detect the rise of this hormone. The luteinizing hormone is present in the urine, and the amount of the hormones increase before ovulation. So, the ovulation test is to find out the peak fertility time. Ovulation kit offers the advantage of testing at home, and with the help of a urine ovulation test kit, someone can detect the luteinizing hormone along with estrogen. Ovulation test can also be done through luteinizing hormone levels in urine, electrolyte levels in saliva, or the body temperature.
There are different types of ovulation test kits available in the market, and these kits either use a sample of urine or saliva for the test of women’s hormones. The global ovulation test market is showing rapid growth due to the increase in fertility rates across the world. Ovulation kits are easy to use, and they can be used without the help of a healthcare professional—these tests are used by women who are trying to conceive. In case of a positive ovulation test, the kit will identify the presence of hormones easily. The rising first-time pregnancy age among women is one of the major factors contributing to the expansion of the ovulation test kit. Increasing awareness among people regarding the advantages of ovulation test kits will help to boost the ovulation test market in the forecast period.
The ovulation kit gives 99% accurate results, and the rising demand for these kits due to accurate results will drive ovulation test market growth. Apart from that, the easy availability of ovulation test kits in medical stores and rising first-time pregnancies will boost the ovulation test global market revenue in the forecast period. Additionally, the declining fertility rate in the world is likely to fuel the fertility and pregnancy rapid test kits market.
Covid-19 pandemic was because of the coronavirus outbreak. Due to this, many countries were suffering from the financial crisis, and many businesses were going through tough times. Further, the imposition of lockdown by the government made things worse for both the public and private sectors. Only the healthcare sector was highly benefitted by this covid-19 situation. All the shops and business organizations were shut down apart from the healthcare sector. Due to the work-from-home culture, people mostly stayed at home, and they got a long break from their work. The break from their busy lives gave them the advantage to spend time with their family. At this time, the pregnancy rates got higher, and it had a positive impact on the ovulation test kit market. As local stores were open it there was no problem in the availability; however, the low production of ovulation test kits decreased the demand of the ovulation test market. The ovulation kit test market is expected to rise rapidly after the post-covid-19 situation.
Figure 2: Market Synopsis of Ovulation Test Market by type, 2016 (%):
Regional Analysis of Ovulation Test Market:
Rising in various types of diseases such as Polycystic Ovary Syndrome (PCOS) and other health issues will drive the ovulation test market. Apart from that increased number of first-time pregnancies and low fertility rates across the globe will drive the ovulation test market in the coming years. Now, most of the countries are technologically advanced, and they are adopting a digital method to test. The growth in the adoption of fertility testing in these countries and the availability of advanced technology with high accuracy is driving the ovulation test global market growth. The increasing awareness about family planning is expected to drive the ovulation test market furthermore. The complications of pregnancy are rising globally, and it is expected to boost the global ovulation test market growth. The ovulation test kit is affordable, and they give 99% accurate results from home, and it is attracting vendors. To avoid unwanted pregnancy and to maintain better health facilities for a child will propel this market in the coming years.
The lifestyle of people is changing over time, and now countries are developing economically. The increase in the per capita income of people and adoption of kits for ovulation and pregnancy testing will bring more opportunities for the ovulation test market. In past years people had to go to the hospitals for an ovulation test. With time the technology has changed, and now people can test from the comfort of their home. So, the increasing adoption of digital technology will generate more opportunities for the ovulation test market.
The ovulation test can’t confirm ovulation, and it only detects the luteinizing hormones that cause ovulation. Ovulation test won’t if the user has consumed any drugs. Ovulation test also won’t work for people above 40 age and for the user suffering from PCOS/PCOD. All these factors can be restraints in the ovulation test market growth.
There are many undeveloped regions that are not aware of the use of ovulation kits, and the low awareness of the benefits of the kits in those areas is a big challenge for the ovulation test market. The key players of the ovulation test market and drivers will overcome these challenges in the coming years.
Cumulative growth analysis
The ovulation test market was valued at USD 1000 million in 2016, and it is expected to reach USD 2500 million in the forecast period with a CAGR level of 4.5% By 2023. The increasing adoption of advanced technology, increasing awareness of the benefits of ovulation test kits, and the growing number of health problems will boost the ovulation market growth in the coming years.
The ovulation test market is segmented on the basis of test type, application, and region.
The major regions of the ovulation test market are North America, Europe, Asia Pacific, and the rest of the world. North America holds the highest share in the ovulation test market revenue, and it is expected to dominate the market throughout the forecast period due to the increasing awareness of big planned pregnancy and easy availability of testing devices in this region. North America is expected to reach USD 900 million with a CAGR rate of 2.2% in the forecast period. It was valued at USD 550 million in 2016. Europe following North America, and it holds the second-highest share in the ovulation test market. Europe is expected to register a CAGR rate of 1.24% in the forecast period. Asia Pacific is expected to register the highest CAGR in the market due to the increasing population in the countries like China and India. China and India are the largest populated countries in the world. The government initiatives to control the population and an increasing number of planned population will boost the demand for the ovulation test market in this region.
The major key players in the countries are:
Among these, Clearblue ovulation test kits are in high demand. The Clearblue advanced digital ovulation test kits are contributing highly to the ovulation test market.
At-home fertility test maker Proov is expanding in Europe after receiving CE marking for its ovulation-confirming test kit.
|Market Size||USD 3642.96 Million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors and Trends|
|Segments Covered||Type and End user|
|Geographies Covered||North America, Europe, Asia-Pacific and Rest of the World (RoW)|
|Key Vendors||Swiss Precision Diagnostics GmbH (Switzerland), Church & Dwight Co. Inc. (U.S.), Prestige Brands Holdings Inc. (U.S.), HiLin Life Products Inc. (U.S.) and Fairhaven Health LLC (U.S.), Fertility Focus Limited (U.K.), Geratherm Medical AG (Germany), Accuquik (California), NecLife (India) and Piramal Healthcare (India)|
|Key Market Opportunities||
|Key Market Drivers||
The valuation of the global ovulation test market had reached USD 3642.96 Million in 2030.
The valuation of the global ovulation test market is estimated to increase to USD 2500 MN by the end of 2023.
The global ovulation test market is projected to grow at 6.3% CAGR during the assessment period (2022-2030).
North America holds the largest share in the global ovulation test market, followed by Europe and the Asia Pacific, respectively.
Church & Dwight Co. Inc. (US), Swiss Precision Diagnostics GmbH (Switzerland), Prestige Brands Holdings Inc. (US), Fairhaven Health LLC (US), HiLin Life Products Inc. (US), Fertility Focus Limited (UK), Accuquik (California), Geratherm Medical AG (Germany), NecLife (India), and Piramal Healthcare (India), are some of the major players operating in the ovulation test market.